Form 4: Evolus Director Albert G. White III Boosts Stake with Significant Common Stock Purchase

Evolus, Inc. Director Albert G. White III has acquired 20,000 shares of common stock at a weighted average price of $9.45, increasing his direct beneficial ownership to 50,378 shares.

Summary

• Evolus, Inc. Director Albert G. White III purchased 20,000 shares of the company's common stock on June 9, 2025.
• The shares were acquired at a weighted average price of $9.45 per share, with individual trades ranging from $9.40 to $9.50.
• Following this transaction, Mr. White's direct beneficial ownership in Evolus, Inc. common stock increased to 50,378 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.

Sentiment

Score: 8

Explanation: A director's purchase of a significant number of shares at market price is a strong positive signal, indicating confidence in the company's value and future prospects. The transaction being under a 10b5-1 plan adds a layer of pre-meditation, though the timing of the plan's initiation is not disclosed.

Positives

• A director, Albert G. White III, increased his stake in the company by purchasing 20,000 shares, signaling confidence in the company's future prospects.
• The purchase was made at a weighted average price of $9.45 per share, indicating a significant investment by an insider.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned investment strategy rather than a reaction to immediate market events.

Future Outlook

This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance or outlook, as its purpose is solely to report insider transactions.

Industry Context

Insider purchases, such as this one by a director, can be viewed positively by the market as they often signal management's confidence in the company's valuation and future prospects, potentially differentiating it from competitors where insider selling might be observed.

Comparison to Industry Standards

• While specific comparable companies or projects are not detailed in this Form 4, insider buying is generally considered a positive indicator across industries, suggesting that those with intimate knowledge of the company believe its stock is undervalued or poised for growth.
• The significance of this purchase can be assessed by comparing the transaction size relative to the director's existing holdings and the company's market capitalization, as well as against insider activity in peer companies within the aesthetics or pharmaceutical sectors.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
• Employees might perceive this as a sign of stability and positive outlook from leadership.

Key Dates

Recommendation

Keywords

Evolus, EOLS, Form 4, Insider Trading, Stock Purchase, Director, Beneficial Ownership, Albert G. White III, Equity Acquisition, Rule 10b5-1